A New Statistical Method: Generalized Pairwise Comparisons
Publié le
A New Statistical Method: Generalized Pairwise Comparisons to Assess Treatment Benefit/Risk IN THIS WEBINAR OUR SPEAKERS DESCRIBED A NEW STATISTICAL METHOD,…
Publié le
A New Statistical Method: Generalized Pairwise Comparisons to Assess Treatment Benefit/Risk IN THIS WEBINAR OUR SPEAKERS DESCRIBED A NEW STATISTICAL METHOD,…
Publié le
IDDI, dont l’expertise dans la gestion et l’analyse des données cliniques des patients est mondialement reconnue, fait évoluer son actionnariat…
Publié le
Since the early days of clinical cancer research, given the expected direct cytotoxicity of chemotherapy, tumor shrinkage has been used…
Publié le
Clinical Trial Solutions: Biostatistics and integrated eClinical Services for Phase I-IV Clinical Trials IDDI provides full range of clinical trial…
Publié le
Publié le
Oncology CRO Providing Full Range of Biostatistics and eClinical Solutions IDDI is an oncology CRO led by a highly-skilled biostatistical…
Publié le
Clinical Research Consultants Our Clinical Research Consultants provide Clinical, Statistical and Regulatory Expert Services to accelerate the development of your drug, biomarker…
Publié le
IDDI in the Media BIOWIN Newsletter Deux projets de R&D dans les starting-blocks (July 2017): “TREATBEST, est un consortium composé…
Publié le
IDDI organized a webinar on the Current Status of Surrogates for Survival in Cancer Trials. VIEW THE RECORDING OF THE…
Publié le
IDDI organized a webinar on Personalized Cancer Medicine Needs Randomized Trials. Clinical cancer research is undergoing profound changes, mostly because…